← Back to Search

Dietary Supplement

Turmeric for Arthritis

N/A
Recruiting
Led By Neal Chen, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
40 years of age or older
Tender over basal joint
Timeline
Screening 3 weeks
Treatment Varies
Follow Up enrollment, 6 weeks, and 3 months
Awards & highlights

Study Summary

This trial will test whether turmeric can help manage pain and stiffness for people with basal joint arthritis.

Who is the study for?
This trial is for individuals over 40 with basal joint arthritis who experience pain and stiffness in the thumb. They must have specific symptoms, speak English, and show early-stage arthritis on X-rays. Excluded are those with other inflammatory conditions, taking certain medications like blood thinners or steroids, diabetics, pregnant women, or those pursuing other treatments.Check my eligibility
What is being tested?
The study tests if turmeric can help manage pain and stiffness from basal joint arthritis compared to a placebo. Participants will be randomly assigned to receive either turmeric supplements or a placebo in this pilot Randomized Controlled Trial.See study design
What are the potential side effects?
While not specified here, common side effects of turmeric may include stomach upset, nausea, dizziness or diarrhea. Placebos typically have no active ingredients but can cause side effects based on participants' expectations.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 40 years old or older.
Select...
I have pain when touching the base of my thumb.
Select...
My condition is in the early stages according to my X-rays.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~enrollment, 6 weeks, and 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and enrollment, 6 weeks, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in baseline disability
Change in baseline pain intensity

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: TurmericExperimental Treatment1 Intervention
Subjects in this group will receive turmeric (100 mg pastille) 3 times per day for 6 weeks.
Group II: ControlPlacebo Group1 Intervention
Subjects in this group will receive a placebo pill 3 times per day for 6 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Turmeric
2011
Completed Phase 3
~480

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,933 Previous Clinical Trials
13,198,461 Total Patients Enrolled
20 Trials studying Osteoarthritis
4,610 Patients Enrolled for Osteoarthritis
Neal Chen, MDPrincipal InvestigatorMassachusetts General Hospital
10 Previous Clinical Trials
13,876 Total Patients Enrolled
3 Trials studying Osteoarthritis
218 Patients Enrolled for Osteoarthritis

Media Library

Turmeric (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT03017118 — N/A
Turmeric (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03017118 — N/A
Osteoarthritis Research Study Groups: Control, Turmeric
Osteoarthritis Clinical Trial 2023: Turmeric Highlights & Side Effects. Trial Name: NCT03017118 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What site did they apply to?
Massachusetts General Hospital
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

AWAYS happy to help with trials for the betterness of humanity.
PatientReceived 1 prior treatment
~2 spots leftby Dec 2024